MYOCURE entering the second phase
The first official MYOCURE Progress Report has been approved by the European Commission. The report shows the progress the consortium has made within the first 18 month of the project towards the overall goal of finding a cure for rare inherited muscle diseases. The foundation has now been laid and the partners are eager to enter the second phase of the project lifetime.
The full publishable summary of the report can be found here.